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Abstract
In the last decades in vitro studies highlighted the potential for crosstalk between Hyp-
oxia-Inducible Factor-(HIF) and glucocorticoid-(GC) signalling pathways. However, how
this interplay precisely occurs in vivo is still debated. Here, we use zebrafish larvae
(Danio rerio) to elucidate how and to what degree hypoxic signalling affects the endoge-
nous glucocorticoid pathway and vice versa, in vivo. Firstly, our results demonstrate that
in the presence of upregulated HIF signalling, both glucocorticoid receptor (Gr) respon-
siveness and endogenous cortisol levels are repressed in 5 days post fertilisation larvae.
In addition, despite HIF activity being low at normoxia, our data show that it already
impedes both glucocorticoid activity and levels. Secondly, we further analysed the in vivo
contribution of glucocorticoids to HIF activity. Interestingly, our results show that both glu-
cocorticoid receptor (GR) and mineralocorticoid receptor (MR) play a key role in enhanc-
ing it. Finally, we found indications that glucocorticoids promote HIF signalling via multiple
routes. Cumulatively, our findings allowed us to suggest a model for how this crosstalk
occurs in vivo.
Author summary
Hypoxia is a common pathophysiological condition to which cells must rapidly respond
in order to prevent metabolic shutdown and subsequent death. This is achieved via the
activity of Hypoxia-Inducible Factors (HIFs), which are key oxygen sensors that mediate
the ability of the cell to cope with decreased oxygen levels. Although it aims to restore tis-
sue oxygenation and perfusion, it can sometimes be maladaptive and contributes to a vari-
ety of pathological conditions including inflammation, tissue ischemia, stroke and growth
of solid tumours. In this regard, synthetic glucocorticoids which are analogous to natu-
rally occurring steroid hormones, have been used for decades as anti-inflammatory drugs
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for treating pathological conditions which are linked to hypoxia (i.e. asthma, rheumatoid
arthritis, ischemic injury). Indeed, previous in vitro studies highlighted the presence of a
crosstalk between HIF and glucocorticoids. However, how this interplay precisely occurs
in an organism and what the molecular mechanism is behind it are questions that still
remain unanswered. Here, we provide a thorough in vivo genetic analysis, which allowed
us to propose a logical model of interaction between glucocorticoid and HIF signalling. In
addition, our results are important because they suggest a new route to downregulate HIF
for clinical purposes.
Introduction
Glucocorticoids (GC) constitute a well-characterized class of lipophilic steroid hormones pro-
duced by the adrenal glands in humans and by the interrenal tissue in teleosts. The circadian
production of glucocorticoids in teleosts is regulated by the hypothalamus-pituitary-interrenal
(HPI) axis, which is the equivalent of the mammalian hypothalamus-pituitary-adrenal (HPA)
axis. Both are central to stress adaptation [1–4]. Interestingly, both in humans and teleosts cor-
tisol is the primary glucocorticoid and regulates a plethora of physiological processes including
glucose homeostasis, inflammation, intermediary metabolism and stress response [5]. In par-
ticular, cortisol can exert these functions via direct binding both to the glucocorticoid receptor
(Gr) and to the mineralocorticoid receptor (Mr), which bind cortisol with different affinities.
[3,6]. Together they act as a transcription factor, which can function either in a genomic or in
non-genomic way [5,7–9].
Hypoxia-inducible factor (HIF) transcription factors are key regulators of the cellular
response to hypoxia, which coordinate a metabolic shift from aerobic to anaerobic metabolism
in the presence of low oxygen availability in order to assure homeostasis [10]. In mammals
there are at least three isoforms of HIF-ċ (HIF-1ċ, HIF-2ċ and HIF-3ċ) and two main iso-
forms of HIF-1Č (ARNT1 and ARNT2). [11]. Interestingly, due to a genome duplication
event, there are two paralogs for each of the three Hif-ċ isoforms (Hif-1ċa, Hif-1ċb, Hif-2ċa,
Hif-2ċb, Hif-3ċa and Hif-3ċb) in zebrafish. Among these, Hif-1ċb is thought to be the key
zebrafish homologue in the hypoxic response [12]. With respect toHIF-1Č (ARNT) paralogues,
the expression of two genes encoding Arnt1 and Arnt2 proteins has been described in zebra-
fish [13–16].
Whilst ARNT is constitutively expressed in the nucleus, the cytoplasmic HIF-ċ subunits are
primarily regulated post-translationally via the PHD3-VHL-E3-ubiquitin ligase protein degra-
dation complex. This is believed to occur in order to allow a rapid response to decreasing oxy-
gen levels [12,17–19]. Indeed, hypoxia, is a common pathophysiological condition [20,21] to
which cells must promptly respond in order to avert metabolic shutdown and subsequent
death [12]. In the presence of normal oxygen levels, a set of prolyl hydroxylases (PHD1, 2 and
3) use the available molecular oxygen directly to hydroxylate HIF-ċ subunit. Hydroxylated
HIF-ċ is then recognised by the Von Hippel Lindau (VHL) protein, which acts as the substrate
recognition part of a E3-ubiquitin ligase complex. This leads to HIF-ċ proteasomal degrada-
tion to avoid HIF pathway activation under normoxic conditions. On the other hand, low O2
levels impair the activity of the PHD enzymes leading to HIF-ċ stabilisation and subsequent
translocation in the nucleus. Here, together with the HIF-Č subunit, HIF-ċ forms a functional
transcription complex, which drives the hypoxic response [22]. Although the HIF response is
aimed to restore tissue oxygenation and perfusion, it can sometimes be maladaptive and can
contribute to a variety of pathological conditions including inflammation, tissue ischemia,
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stroke and growth of solid tumours [23]. Finally, it is important to note for this study that HIF
signalling is able to regulate its own activation via negative feedback, by inducing the expres-
sion of PHD genes, in particular prolyl hydroxylase 3 (PHD3) [24,25].
The presence of a crosstalk between glucocorticoids and hypoxia dependent signalling path-
ways has been reported in several in vitro studies [26–30]. Moreover, synthetic glucocorticoids (ie.
betamethasone and dexamethasone), which are analogous to naturally occurring steroid hor-
mones, have been extensively used for decades as anti-inflammatory drugs for treating pathologi-
cal conditions which are linked to hypoxia (i.e. asthma, rheumatoid arthritis, ischemic injury, etc.)
[31–33]. However, due to the presence of adverse effects [34] and glucocorticoid resistance
[35,36], their use has been limited. Therefore, extending the research on how precisely this inter-
play occurs in vivo, may have a wide physiological significance in health and disease.
The first evidence of interaction between HIF and GR was provided by Kodama et al. 2003
[26], who discovered that ligand-dependent activation of glucocorticoid receptor enhances
hypoxia-dependent gene expression and hypoxia response element (HRE) activity in HeLa
cells. Leonard et al. 2005 [27] subsequently revealed that GR is transcriptionally upregulated
by hypoxia in human renal proximal tubular epithelial cells. Furthermore, the hypoxic upregu-
lation of GR was confirmed by Zhang et al 2015 [29]. In contrast, a dexamethasone-mediated
inhibition of HIF-1ċ target genes expression in hypoxic HEPG2 cells was demonstrated by
Wagner et al. 2008 [28]. In addition to that, they showed retention of HIF-1ċ in the cytoplasm,
suggesting a blockage in nuclear import. Finally, Gaber et al., 2011 [37] indicated the presence
of dexamethasone-induced suppression of HIF-1ċ protein expression, which resulted in
reduced HIF-1 target gene expression.
From these in vitro results it has become clear that the HIF-GC crosstalk is complex and
may depend on cell type. In the present study, we have used the zebrafish (Danio rerio) as an
in vivomodel organism to study how and to what degree hypoxic signalling affects the endoge-
nous glucocorticoids’ response and vice versa. The use of whole animals allows us to show how
these signals interact at a more global level than in cell culture, where interactions between dif-
ferent tissues and cell types are not easily modelled. The zebrafish offers an excellent genetic
vertebrate model system for endocrine studies, and similar to humans, they are diurnal and
use cortisol as the main glucocorticoid hormone [38]. Importantly, unlike other teleosts, zebra-
fish have only a single glucocorticoid (zGr) and mineralocorticoid receptor (Mr) (zMr) iso-
form [3]. Moreover, zGr shares high structural and functional similarities to its human
equivalent, making zebrafish a reliable model for studying glucocorticoids activity in vivo [39–
41]. Additionally, zebrafish share all the components of the human HIF signalling pathway
and it has been proved to be a very informative and genetically tractable organism for studying
hypoxia and HIF pathway both in physiological and pathophysiological conditions [12,25,42].
In our previous work, we identified new activators of the HIF pathway, e.g. betamethasone,
a synthetic glucocorticoid receptor agonist [43]. Counterintuitively, GR loss of function was
shown by Facchinello and colleagues to hamper the transcriptional activity linked to immune-
response (i.e of cytokines Il1Č, Il8 and Il6 and of the metalloproteinase Mmp-13) [5]. Finally,
glucocorticoid receptor has been also found to synergistically activate proinflammatory genes
by interacting with other signalling pathways [40,44–46].
In the present study, we utilised both a genetic and pharmacological approach to alter these
two pathways during the first 120 hours post fertilisation of zebrafish embryos. In particular,
we took advantage of two different mutant lines we have generated (hif1Čsh544 (arnt1) and
grsh543 (nr3c1) respectively), coupled to an already existing vhlhu2117/+;phd3::EGFPi144/i144 hyp-
oxia reporter line [25], to study the effect of HIF activity on GC signalling and vice-versa, via a
“gain-of-function/loss-of-function” approach. Phenotypic and molecular analyses of these
mutants have been accompanied by optical and fluorescence microscope imaging.
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Importantly, we not only confirm that betamethasone is able to increase the expression of
phd3:eGFP, a marker of HIF activation in our zebrafish HIF-reporter line, but we also show
that BME-driven HIF response requires Hif1Č/Arnt1 action to occur.
Furthermore, our results also demonstrate that both Gr and Mr loss of function are able to
partially rescue vhl phenotype, allowing us to confirm the importance of glucocorticoids in
assuring high HIF signalling levels. This finding may have wider significance in health and dis-
ease, as so far it is proven difficult to downregulate HIF signalling.
Our results also demonstrate that in the presence of upregulated HIF pathway (by mutating
vhl), both the glucocorticoid receptor activity and the endogenous cortisol levels are repressed
in 5 dpf larvae, whereas when the HIF pathway is suppressed (by mutating hif1Č) they are sig-
nificantly increased. Finally, qPCR analysis on GC target genes, in situ hybridisation on the
expression of steroidogenic genes and cortisol quantification on the aforementioned mutant
lines confirmed our hypothesis.
Taken together, these results allow us to deepen the knowledge of how the crosstalk
between HIF and glucocorticoid pathway occurs in vivo and to underscore a new model of
interaction between these two major signalling pathways.
Results
Generating arnt1 and arnt1;vhl knockout in zebrafish:
To study the interplay between HIF and GC signalling in vivo, using a genetic approach, we
required a Hif1Č/Arnt1 mutant line (in a phd3:eGFP;vhl+/- background) to enable the downre-
gulation of the HIF pathway. Hif-1Č (hypoxia-inducible factor 1 beta, Arnt1) is a basic helix-
loop-helix-PAS protein which translocates from the cytosol to the nucleus after ligand binding
to Hif-ċ subunits, after the stabilization of the latter in the cytoplasm. It represents the most
downstream protein in the HIF pathway and for this reason it is the most suitable target.
Using CRISPR mutagenesis we obtained a 7 bp insertion in exon 5 (coding bHLH DNA
binding domain (DBD) of the Hif-1Č protein; allele name sh544) in vhl heterozygote embryos
(Fig 1A). The resulting frameshift mutation was predicted to lead to a premature stop codon
at the level of the DNA-binding domain, which would result in a severely truncated protein.
The resulting line hif1Čsh544/+;vhlhu2117/+;phd3:eGFPi144/i144 will be called arnt1+/-;vhl+/-,
whereas the vhlhu2117/+;phd3:eGFPi144/i144 line will be called vhl+/- hereafter.
Initial analysis performed on arnt1+/-;vhl+/- incross-derived 5 dpf larvae (F1 generation)
confirmed the suppressive effect that arnt1mutation was expected to have on vhlmutants.
Overall, arnt1-/-;vhl-/- larvae showed a substantially attenuated vhl phenotype, characterized by a
reduced phd3:eGFP related brightness, especially in the liver (Fig 1C’), with the absence of peri-
cardial edema, excessive caudal vasculature and normal yolk usage (Fig 1C) compared to vhl-/-
larvae (Fig 1B and 1B’). In particular, this was quantified as a 39% downregulation (P<0.0017)
at the level of the head, a 75% downregulation (P<0.0001) in liver and a 58% downregulation
(P<0.0001) in the rest of the body (from the anus to the caudal peduncle), in terms of phd3:
eGFP-related brightness, compared to vhl-/- larvae (Figs 1C’, 1B’, S1A and S1D).
Furthermore, since homozygous vhlmutants are lethal by 8-10dpf [47], we analysed the
efficacy of arnt1mutation in rescuing vhl phenotype. To this end, we attempted to raise
arnt1-/-;vhl-/- after day 5 post fertilization. Notably, double mutants were able to survive beyond
15 dpf, but failed to grow and thrive when compared to their wild-type siblings, which led us
to euthanise them due to health concerns at 26 dpf (S1B Fig). Of note, arnt1 homozygotes, in
a vhl/+ or wt background, were morphologically indistinct and adults were viable and fertile.
In contrast, the previously published arnt2-/- zebrafish larvae were embryonic lethal around
216 hpf [14].
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Arnt1 and Arnt2 are mutually required for HIF signalling in zebrafish
As arnt1;vhl double mutants still activate the phd3:eGFPHIF reporter, we examined the
importance of Arnt2 isoform in the HIF pathway. Phenotypic analysis was carried out on 5
dpf Arnt2 CRISPANTs, created both in a vhl+/- and arnt1+/-;vhl+/- background, according to
the protocol of Wu et al., 2018 [48]. By analysing the expression of the phd3:eGFP transgene,
we observed that arnt2 CRISPR injected vhlmutants were characterized by a significant down-
regulation of phd3:eGFP-related brightness at the level of the head (equals to 53%, P<0.0001),
in the liver (equals to 54%, P<0.0001) and in the rest of the body (equals to 46%, P<0.0001),
compared to uninjected vhlmutant larvae (Fig 1H’ compared to 1H, white asterisks; Fig 1K).
Furthermore, when both arnt1 and arnt2 isoforms were simultaneously knocked-out (Fig
1I’), the downregulation was even stronger at the level of the head (equals to 74%, P<0.0001),
the liver (equals to 86%, P<0.0001) and in the rest of the body (equals to 83%, P<0.0001) (Fig
1I’ compared to 1H; Fig 1K). Of note, phd3:eGFP-related brightness in these mutants was still
slightly higher than wildtype, (not shown; these levels are undetectable). Overall, these data
show that Arnt1, even if not fundamental for survival, is the main isoform in the zebrafish
liver required for HIF signalling, whereas Arnt2 is more expressed in the developing central
nervous system (CNS), as reported by Hill et., al 2009. Of note, since both isoforms can form a
functional complex with Hif-ċ isoforms and appear to function in the same organs, this allows
us to confirm that they have partially overlapping functions in vivo and to show that they syn-
ergistically contribute to the HIF response.
Modulation of HIF signalling affects GR signalling
To investigate the interaction between HIF and glucocorticoid signalling, we quantified the
expression of four potential glucocorticoid target genes from mammalian studies (fkbp5, il6st,
pck1 and lipca) both in a HIF upregulated (vhl-/-), and downregulated scenario (arnt1-/-) via
RTqPCR analysis on 5 dpf larvae. We confirmed that in zebrafish larvae, fkbp5 is the most sen-
sitive and well-established readout of Gr activity [5,49,50], whilst the other aforementioned
genes do not directly take part in the GC-GR negative feedback loop. Therefore, we focused
this analysis on fkbp5.
Interestingly, our analysis shows that the expression of fkbp5 is downregulated (fold
change = 0.1; P = 0.0035) in the presence of an upregulated HIF pathway (vhl-/-) compared to
DMSO treated vhl siblings (Fig 2A). Vice versa, when the HIF pathway is suppressed
Fig 1. arnt1 and arnt2 have partially overlapping functions and synergistically contribute to HIF signalling. A. Schematic representation of zebrafish hif1Č
(arnt1) gene. Exons are shown as black boxes, whereas introns as lines. The red arrowhead shows the position of a +7 bp insertion in exon 5 (encoding the
bHLHDNA binding domain). In the arnt1 wt and mutant sequence. CRISPR target site: bold. Protospacer-adjacent-motif (PAM) sequence: red. B-B’.
Magnified picture of a representative 5 dpf vhl-/- larva compared to 5dpf arnt1-/-;vhl-/- (C-C’). Among the 120 GFP+ embryos derived from arnt1+/-;vhl+/-(phd3:
eGFP) x arnt1-/-;vhl+/-(phd3:eGFP), 15 larvae were characterized by the absence of pericardial oedema, no ectopic extra vasculature at the level of the tail, no
bright liver and a reduced brightness in the rest of the body (black and white arrowheads). Genotyping post phenotypic analysis on sorted larvae confirmed
genotype-phenotype correlation. Fluorescence, exposure = 2 seconds. Scale bar 200 μm. D-G. Representative picture of phenotypic analysis performed on
DMSO and BME [30 μM] treated 5 dpf larvae, derived from arnt1+/-;vhl+/-(phd3:eGFP) x arnt1-/-;vhl+/-(phd3:eGFP) (n = 540). All the genotype combinations
observed are represented in the figure. Among the 405 GFP+ larvae, all the 25 arnt1-/-;vhl-/- showed the aforementioned partially rescued vhl phenotype (D).
Fluorescence, exposure = 2 seconds. Scale bar 500 μm. H-J. Representative pictures of 5 dpf CRISPANTmutants created by redundantly targeting arnt2 gene
via co-injection of 4x gRNAs in arnt1+/-;vhl+/-(phd3:eGFP) x arnt1-/-; vhl+/-(phd3:eGFP) derived embryos (n = 300). Uninjected embryos were used as control
(n = 120). White asterisks: head, liver and tail ragions. Fluorescence, exposure = 991,4 ms. Scale bar 500 μm. K. Statistical analysis performed on mean grey
values quantification (at the level of the head, liver and tail), after phenotypic analysis on 5 dpf arnt2 4x gRNAs injected and uninjected larvae. vhl-/- uninjected
n = 8 larvae: head 93.1 ± 2.33 (mean ± s.e.m); liver 99.65 ± 3.49 (mean ± s.e.m); tail 29.58 ± 0.73 (mean ± s.e.m). arnt1-/-;vhl-/- uninjected n = 10 larvae: head
56.49 ± 3.36 (mean ± s.e.m); liver 24,7 ± 2.36 (mean ± s.e.m); tail 12.39 ± 0,75 (mean ± s.e.m). vhl-/- injected n = 12 larvae: head 43.69 ± 3.25 (mean ± s.e.m);
liver 45.54 ± 4.57 (mean ± s.e.m); tail 16.09 ± 1.37 (mean ± s.e.m). arnt1-/-;vhl-/- injected n = 11 larvae: head 24.66 ± 1.63 (mean ± s.e.m); liver 13.88 ± 0.66
(mean ± s.e.m); tail 5.16 ± 0.33 (mean ± s.e.m). Ordinary One-way ANOVA followed by Sidak’s multiple comparison test (�P< 0.05; ��P< 0.01; ���P<0.001;
����P< 0.0001).
https://doi.org/10.1371/journal.pgen.1008757.g001
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Fig 2. HIF signalling inversely correlate with GC transcriptional activity and cortisol biosynthesis. A. Schematic view of RTqPCR
analysis on fkbp5 expression performed on the vhl+/-(phd3:eGFP) and the arnt1+/-(phd3:eGFP) mutant lines at 5 dpf:. Upregulated (in
vhl-/-) HIF signalling repressed Gr activity, whereas arnt1 loss of function derepressed it. Statistical analysis was performed on ïïCt values,
whereas data are shown as fold change values for RTqPCR analysed samples; ordinary Two-way ANOVA followed by Dunnett’s multiple
PLOS GENETICS Crosstalk between HIF and glucocorticoid signalling
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(arnt1-/-), fkbp5 expression is upregulated (fold change = 24.1; P<0.0001), compared to
DMSO treated wild-type levels (Fig 2A’).
To further examine the effect of HIF signalling on glucocorticoid responsiveness, we also
performed betamethasone (BME) treatment [30 μM] on the aforementioned mutant lines, fol-
lowed by RTqPCR analysis. Of note, BME was able to increase fkbp5 expression in vhl siblings
and was only able to mildly do that in vhlmutants. Indeed, its induction levels appeared not
only lower in BME treated vhlmutants (fold change = 2.1) than in BME treated siblings (fold
change = 7, P = 0.0286), but also its expression was not significantly different from DMSO
treated wild-types (Fig 2A). In contrast, when the HIF pathway was suppressed (arnt1-/-),
BME treatment was able to further upregulate the expression of fkbp5 (fold change = 107,5;
P = 0.0031), compared to DMSO treated arnt1mutants (Fig 2A’).
Collectively, we speculate that the upregulated HIF levels are able to repress the glucocorti-
coid receptor activity and can blunt its responsiveness to an exogenous GR agonist (BME treat-
ment). On the other hand, importantly, although HIF activity is expected to be low in wild-
type larvae in a normoxic environment, its function is also detectable with respect to suppres-
sion of GR activity. Indeed, if arnt1 gene is knocked-out (arnt1-/-) an increased GR sensitivity
is observed (Fig 2A’). To further test whether this had repercussions on steroidogenesis and/or
cortisol levels, we analysed them both in a HIF upregulated (vhl-/-) and downregulated sce-
nario (arnt1-/-).
HIF signalling acts as negative regulator of steroidogenesis
To investigate the relationship between HIF signalling and steroidogenesis, we initially per-
formed in situ hybridization on larvae obtained from the arnt1+/-mutant line, using both pro-
opiomelanocortin (pomca) and Cytochrome P450 family 17 polypeptide 2 (cyp17a2) as probes.
Expression of pomca, at the level of the anterior part of the pituitary gland, is a well-established
readout of GR function in zebrafish larvae. Pomca is negatively regulated by increased blood
cortisol levels via GC-GR signalling, as part of the HPI axis feedback loop [4,51]. Previous
comparison test (�P< 0.05; ��P< 0.01; ���P<0.001; ����P< 0.0001). B-C’. Representative pictures of WISH performed on DMSO and
BME [30 μM] treated arnt1 mutant line, at 5 dpf, using pomca as probe. arnt1 wt DMSO treated (n = 30/30 larvae) showed normal pomca
expression; arnt1 wt BME treated (n = 29/30 larvae) showed downregulated pomca expression. In contrast, arnt1-/-DMSO treated (n = 28/
30) and arnt1-/- BME treated (n = 30/30) larvae showed downregulated pomca expression. Chi-square test (����P< 0.0001). Scale bar
50 μm. D-E’. Representative pictures of WISH performed on DMSO and BME [30 μM] treated vhlmutant line, at 5 dpf, using pomca as
probe. DMSO treated vhl siblings (n = 26/28) showed normal pomca expression; BME treated vhl siblings (n = 28/30) showed
downregulated pomca expression. In contrast, vhl-/-DMSO (n = 28/29) and BME (n = 28/28) treated larvae showed downregulated pomca
expression. Chi-square test (����P< 0.0001). Scale bar 50 μm. F-F’. Steroid quantification results showed a significantly reduced cortisol
concentration (P value<0;0028) in vhlmutants (92.7 fg/larva, in triplicate), compared to vhl siblings (321 fg/larva, in triplicate) at 5 dpf (F).
Moreover, a significantly increased cortisol concentration (P value<0;0001) was measured in arnt1mutants (487.5 fg/larva, in triplicate),
compared to arnt1 wild-types (325 fg/larva, in triplicate) at 5 dpf (F’); unpaired t-test (��P< 0.01; ���P<0.001). G.DMSO: Speculative
scheme of how the putative HIF-GC crosstalk occur in wildtypes and how it is affected both in arnt1-/- and in vhl-/- larvae at 5 dpf. In
wildtype scenario HIF signalling helps the GC-GR negative feedback to protect the body from an uncontrolled stress response. In
particular, we speculate that HIF transcriptional activity is able to inhibit pomca expression when cortisol levels arise over a certain
threshold in order to maintain both HIF and GC basal levels. However, in arnt1-/- scenario, the HIF-mediated negative feedback is
compromised by the lack of a functional Arnt1. This triggers an initial uncontrolled pomca expression, which increases cortisol levels and
subsequently downregulate pomca expression itself. Vicersa, in vhl-/- scenario, the HIF-mediated negative feedback can exert a stronger
inhibition of pomca due to the presence of upregulated HIF signalling. This results both in downregulated cortisol levels and in a
suppressed GR responsiveness. However, the presence of alternative mechanisms cannot be completely excluded (i.e HIF might interact
more directly with GC/GR to impair its function). Finally, the combination high cortisol/low pomca is very rare and this combination may
change over the course of development. G. BME: Speculative scheme of how the putative HIF-GC crosstalk occur in wildtypes and how it is
affected both in arnt1-/- and in vhl-/- larvae at 5 dpf, after BME[30μM] treatment. In all the cases, because of betamethasone acts
downstream of the HPI axis, by binding directly to Gr, it is able to upregulate glucocorticoid target genes expression. Consequently, since
GC are able to stimulate HIF signalling, as expected, we observed an increase phd3:eGFP-related brightness both in wildtypes and in vhl-/-.
However, the fact that we did not observed any HIF upregulation both in arnt1-/- and in arnt1-/-;vhl-/-, highlighted the fact that the BME-
induced HIF signalling activation is an Arnt1 dependent mechanism.
https://doi.org/10.1371/journal.pgen.1008757.g002
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work also suggested that HIF promotes POMC activity in the mouse hypothalamic region
[52]. On the other hand, Cyp17a2 is an enzyme involved in steroid hormone biosynthesis at
the level of the interrenal gland, which is activated upon ACTH stimulation [53–55].
We found that 5 dpf arnt1-/- larvae, which were characterized by an upregulated GC
responsiveness, showed upregulated cyp17a2 expression (S3C–S3C’ Fig) coupled to downre-
gulated pomca (Fig 2C). As expected, arnt1 siblings showed normally expressed cyp17a2
(S3A–S3A’ Fig) and pomca (Fig 2B), which were observed to be downregulated only as a con-
sequence of BME treatment (S3B–S3B’ and S2B’ Figs). Therefore, we speculate that in the
absence of arnt1 (HIF suppressed scenario), pomca downregulation is most likely to occur as a
consequence of GC-GR induced negative feedback loop, triggered by putative high cortisol
levels (Fig 2A and 2G, DMSO, arnt1mutant).
We subsequently examined both pomca and cyp17a2 expression in the opposite -HIF upre-
gulated- scenario, by performing WISH analysis on the vhlmutant line. Interestingly, 5 dpf
vhl-/- larvae, which were characterized by a downregulated GR activity, displayed downregu-
lated cyp17a2 expression (S3G–S3G’ Fig), coupled to downregulated pomca expression (Fig
2E). On the other hand, vhl siblings showed normally expressed pomca (Fig 2D), which was
observed to be downregulated after BME treatment, as expected (Fig 2D’). Consequently, we
speculate that in the absence of vhl (HIF upregulated scenario), pomca downregulation is most
likely to occur as a consequence of HIF-mediated downregulation of pomca expression. (Fig
2G, DMSO, vhlmutant).
Cumulatively, if this is true, we predicted to observe reduced levels of endogenous cortisol
in vhl-/- larvae and normal or even increased levels in arnt1-/- larvae at 5 dpf.
Steroidogenesis is repressed in vhl-/- and derepressed in arnt1-/-
To confirm this hypothesis, we performed cortisol quantification on the aforementioned vhl
and arnt1mutant lines. Interestingly, cortisol concentration was significantly reduced (P value
<0.0028) in vhlmutant larvae (92,7 fg/larva), compared to vhl siblings (321 fg/larva) (Fig 2F).
Conversely, cortisol was significantly increased (P value<0.0001) in arnt1mutants (487.5 fg/
larva), compared to arnt1 siblings (325 fg/larva) (Fig 2F’).
Taken together, these data confirmed our hypothesis and showed for the first time that HIF
signalling can act as negative regulator both of GR transcriptional activity and of steroidogene-
sis. Indeed, if only GR transcriptional activity was blocked by HIF, cortisol levels would be
expected to be high in vhlmutants. This is because by blocking GR (i.e as occur in gr-/-), the
GC-GR mediated negative feedback cannot occur, making larvae hypercortisolemic [3,5].
Interestingly, since vhl-/- larvae are characterized both by downregulated cortisol levels and GR
transcriptional activity, this strongly suggests that HIF signalling can act both at the hypotha-
lamic level (to inhibit pomca expression) and intracellularly to block GR transcriptional activ-
ity itself.
Generating gr and gr;vhl knockout in zebrafish
Conversely, to investigate the role of glucocorticoids on the HIF response, we created a novel
glucocorticoid receptor (gr, nr3c1) mutant line and we crossed it with the vhlhu2117/+;phd3::
EGFPi144/i144 hypoxia reporter line (this line will be called gr+/-;vhl+/- hereafter). We created
this line because the existing grs357 allele may still have some activity via non-genomic path-
ways or tethering, promoting HIF activation upon GC treatment [4,43,51]. Of note, grmutants
are hypercortisolemic [3,5]. This is due to the inability of glucocorticoids to bind to a func-
tional receptor (GR). As a result, they fail to provide negative feedback and are not able to shut
down GC biosynthesis [3,5]. We generated an 11 bp deletion at the level of gr exon 3, which is
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predicted to truncate the DNA binding domain, lacks the C-terminal ligand binding domain
and is predicted to be a true null (Fig 3A). The homozygous gr/nr3c1mutants, characterized
during the first 5dpf, were morphologically similar to control siblings and adult fish were via-
ble and fertile, as predicted [5].
To confirm loss-of-function, we initially subjected larvae to a visual background adaptation
(VBA) test, as it is linked to impaired glucocorticoid biosynthesis and action [4,56]. Larvae
derived from gr+/- incross were VBA tested and sorted according to melanophore size at 5 dpf.
PCR-based genotyping on negative VBA-response sorted samples revealed that most larvae
were homozygous for the gr allele, whereas positive VBA-response samples were always gr
siblings.
Furthermore, WISH analysis performed on 5 dpf DMSO and BME treated gr+/- incross
derived larvae using pomca as probe, showed the presence of upregulated pomca expression in
DMSO treated gr-/- at the level of the anterior part of the pituitary gland (Fig 3C), compared to
wild-type siblings (Fig 3B). Of note, BME treatment was not able to downregulate pomca levels
in gr-/-(Fig 3C’), as it occurs in BME treated siblings (Fig 3B’) via GC-GR mediated negative
feedback loop, due to the absence of a functional gr allele. Finally, the loss of function was also
determined in 5 dpf grmutants by the strong downregulation of fkbp5mRNA levels quantified
via RTqPCR, both in the presence (fold change = 0.01; P<0.0001) and in the absence of BME
treatment (DMSO treated, fold change = 0.01; P<0.0001), compared to DMSO treated wild-
types (Fig 3D).
grmutation partially rescues vhl phenotype
We next analyzed the effect of gr loss of function on vhl phenotype. Phenotypic analysis carried
out on 5dpf larvae, derived from gr+/-;vhl+/- incross, revealed that nr3c1mutation was able to
cause an efficient, but not complete rescue of vhl phenotype, in a way which resembled arnt1
mutation (Fig 3F’ and 3G’).
In particular, 5dpf gr-/-;vhl-/- larvae showed a 43% downregulation at the level of the head
(P<0.0001), a 66% downregulation in the liver (P<0.0001) and a 51% downregulation in the
tail (from the anus to the caudal peduncle) (P = 0.0020), in terms of phd3::EGFP-related bright-
ness, compared to vhl-/- larvae (Figs 3G’ compared to 3E’ and S4A). As expected, 5 dpf double
mutant larvae were unable to respond to BME [30 μM] treatment (Figs 3J–3J’ and S4A), as
also confirmed via RTqPCR analysis on HIF (vegfab and egln3) and GC target genes (fkbp5)
(Fig 3H).
Rescue was also apparent by morphology. Indeed, even if gr-/-;vhl-/- showed reduced yolk
usage, they displayed a reduction in ectopic vessel formation at the level of the dorsal tailfin,
no pericardial edema, and developed air-filled swim bladders (Fig 3G and 3E). Moreover,
whilst vhlmutants are inevitably deceased by 10 dpf [47], we were able to raise all selected dou-
ble mutants beyond 15 dpf, but then (similarly to arnt1-/-;vhl-/-) they failed to grow and thrive
when compared to their siblings. This led us to euthanise them due to health concerns at 21
dpf (S4B Fig). Together, these data indicate for the first time, in our in vivo animal model, that
GR function is essential for HIF signalling in zebrafish larvae, particularly at the level of the
head and the liver.
gr loss of function can further reduce HIF signaling in arnt1;vhl double
mutants
The similarity of gr and arnt1mutations could mean they work in a single linear “pathway”. If
true, mutation of both genes should not lead to a further attenuation of the reporter expres-
sion. To test this, we bred the grmutant line with the arnt1;vhl double mutant line and we
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crossed gr+/-;arnt1+/-;vhl+/- triple mutant carriers. Phenotypic analysis carried out on 5 dpf
phd3:eGFP positive larvae (n = 488) showed a small class of larvae with an even more rescued
phenotype and a stronger downregulation of phd3:eGFP related brightness compared both to
arnt1-/-;vhl-/- (Fig 4B–4B’) and gr-/-;vhl-/- double mutants (Fig 4C–4C’). Of note, 7 putative
very weak GFP+ larvae were selected and genotypic analysis confirmed that 5 out of 7 were
indeed gr-/-; arnt1-/-;vhl-/-. In particular, these triple mutants showed a 54% downregulation at
the level of the head, a 71% downregulation in the liver and a 72% downregulation in the tail
region, in terms of phd3:eGFP-related brightness compared to vhl-/- (Figs 4D–4D’ and S5).
Thus, these data suggest that glucocorticoids are likely to interfere with both Arnt1 and Arnt2
mediated HIF signalling pathway.
The BME-induced HIF response is Arnt1 dependent
To further examine the effect of glucocorticoids on HIF signalling, we performed BME [30
μM] treatment on all the available mutant lines. Of note, unlike cortisol, betamethasone has a
very high affinity for Gr, but an insignificant affinity for Mr [57,58]. As expected, 5 dpf wild-
types larvae showed a mild upregulation of phd3:eGFP-related brightness at the hepatic level,
compared to untreated controls (Figs 1G’ and 3L’). BME treatment was also able to further
increase phd3:eGFP-related brightness at the level of the head and the liver of 5 dpf vhl-/-, as
also confirmed by WISH, using both lactate dehydrogenase A (ldha) (Fig 5B–5B’, black
arrowheads) and prolyl hydroxylase 3 (phd3) as probes (Fig 5D–5D’, black arrowheads). As
predicted, both gr-/- and gr-/-;vhl-/- mutants were unaffected due to the absence of functional
Gr (Fig 3K–3K’ and 3J–3J’). Interestingly, in both the arnt1-/-(Fig 1F) and also arnt1-/-;vhl-/-
(Fig 1E) the phd3:eGFP-related brightness did not change after BME treatment (Fig 1E’ and
1F’). This was also confirmed via, RTqPCR analysis carried out on HIF target egln3/phd3 in
the arnt1mutant (S1C Fig; see also arnt1-/-;vhl-/- Fig 3H)
Taken together these data suggest that in vhl-/- larvae, BME treatment can upregulate HIF
signalling by “bypassing” HIF-mediated pomca negative regulation. By directly binding to Gr,
it can compensate for the repressed cortisol levels in vhlmutants. (Fig 2F). On the other hand,
both in arnt1-/- and also arnt1-/-;vhl-/- larvae, even if BME can act downstream of pomca, it can
only upregulate GR responsiveness, but cannot upregulate HIF signalling due to arnt1 loss of
function. Cumulatively, we speculate that even if Arnt2 can interact with the HIF-ċ isoforms
to maintain a moderately upregulated HIF levels (arnt1-/-;vhl-/-), the BME-mediated HIF upre-
gulation is Arnt1 dependent.
Fig 3. grmutation partially rescues vhl phenotype.A. Schematic representation of zebrafish gr (nr3c1) gene. Exons are shown as boxes, introns as lines. The red
arrowhead shows the position of a -11 bp deletion in exon 3 (encoding the DNA binding domain). gr wt and mutant sequence. CRISPR target site: bold. PAM sequence:
red. B-C’. Representative pictures of WISH performed on DMSO and BME [30 μM] treated grmutant line, at 5 dpf, using pomca as probe. Scale bar 100 μm. gr siblings
DMSO treated (n = 30/30 larvae) showed normal expression; gr siblings (n = 29/30 larvae) showed downregulated pomca expression after BME treatment. Both DMSO
treated (n = 30/30) and BME treated (n = 30/30) gr-/- larvae showed upregulated pomca expression. D. RTqPCR analysis performed on gr wt (n = 10; 3 repeats) and gr-/-
(n = 10; 3 repeats) larvae at 5 dpf, using fkbp5 as probe. Statistical analysis was performed on ïïCt values, whereas data are shown as fold change values. Ordinary Two-
way ANOVA followed by Dunnett’s multiple comparison test (����P< 0.0001). E-G. Magnified picture of representative gr-/-; vhl-/- larvae compared to arnt1-/-;vhl-/- and
vhl-/- larvae. Both double mutants are characterized by the absence of pericardial oedema, no ectopic extra vasculature at the level of the tail, no bright liver and a
reduced brightness in the rest of the body (white and black arrowheads), compared to vhl-/- larvae. Fluorescence, exposure = 2 seconds. Scale bar 200 μm. H. RTqPCR
analysis performed both on HIF and GC target genes expression carried out on gr-/-; vhl-/- and sibling at 5 dpf, (n = 10 larvae, per group, in triplicate) compared to
arnt1-/-;vhl-/- larvae and siblings, at 5dpd (n = 10 larvae, per group, in triplicate). Both vegfab and egln3 are HIF target genes, whereas fkbp5 is a GC target gene. Statistical
analysis was performed on ïïCt values, whereas data are shown as fold change values, Ordinary Two-way ANOVA followed by Dunnett’s multiple comparison test. I-L.
Representative picture of phenotypic analysis performed on DMSO and BME [30 μM] treated gr+/-; vhl+/-(phd3::EGFP) incross-derived 5 dpf larvae (n = 600). All the
genotype combinations observed are represented in the figure. Among the 450 GFP+ larvae analysed, 28 showed a partially rescued vhl phenotype which resembled the
arnt1’s one. Three experimental repeats. In all panels: �P< 0.05; ��P< 0.01; ���P<0.001; ����P< 0.0001. Fluorescence, exposure = 2 seconds. Scale bar 500 μm.
https://doi.org/10.1371/journal.pgen.1008757.g003
PLOS GENETICS Crosstalk between HIF and glucocorticoid signalling
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008757 May 7, 2020 12 / 28
grmutation overrides HIF-mediated pomca suppression in a vhl deficient
background
To examine the effect of gr loss of function on steroidogenesis in gr-/-;vhl-/-, we performed
WISH analysis on 5 dpf gr+/-;vhl+/- incross derived larvae, using pomca as probe. As expected,
vhl-/- showed downregulated pomca expression (Fig 4G), whereas gr -/- displayed upregulated
pomca (Fig 4H), compared to wildtypes (Fig 4F). Notably, since a strong upregulation of pro-
opiomelanocortin a was observed in the double mutants (Fig 4I), this suggests that grmutation
overrides HIF-mediated pomca inhibition. PCR-analysis performed post-WISH confirmed
this genotype-phenotype correlation.
These data, in accordance with our hypothesis, suggest that in gr-/-;vhl-/- mutants the upre-
gulation of pomca, triggered by the absence of functional Gr (and of the GC-Gr mediated neg-
ative feedback), cannot be inhibited with the same efficiency by HIF activity at the
hypothalamic level. In gr-/-;vhl-/- mutants, we speculate that the upregulated endogenous corti-
sol interacts with Mr to stimulate the HIF pathway, resulting in a mildly upregulated phd3:
EGFP expression, in-between the levels seen in vhlmutants and wild-type larvae (Fig 3J and
3I). To test this assumption, we set up to block themr gene in a gr-/-;vhl-/- background, in order
to check the importance of Mr in the HIF signaling pathway.
Fig 4. gr loss of function effect is stronger when HIF-signalling is moderately upregulated. A-E. Representative picture of the
main differences between vhl-/-, arnt1-/-;vhl-/-, gr-/-;vhl-/- and triple gr-/-;arnt1-/-;vhl-/- larvae at 5 dpf. Among the 488 phd3:eGFP
expressing larvae analysed, 7 larvae were characterized by the absence of pericardial oedema (black arrowheads, left), no ectopic
extra vasculature at the level of the tail (black arrowheads, right), no visible phd3::EGFPHIF reporter in the liver (white
arrowheads, left) and even more reduced levels of this marker in the head and in the rest of the body (white arrowheads, right).
Genotypic analysis allowed to confirm the presence of a genotype-phenotype correlation in 5 out 7 samples and to prove that they
were triple mutants. Fluorescence, exposure = 2 seconds. Scale bar 200 μm. F-I. Representative pictures of WISH performed on
gr+/-; vhl+/- incross derived larvae, at 5 dpf, using pomca as probe. Of note, gr-/-;vhl-/- showed upregulated pomca expression (20/20
larvae), as observed in gr-/- (20/20 larvae); vhlmutants showed downregulated pomca expression (20/20 larvae), whereas wildtypes
showed normal pomca expression (19/20). Chi-square test (����P< 0.0001). Scale bar 50 μm.
https://doi.org/10.1371/journal.pgen.1008757.g004
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Both Gr and Mr are directly required in the HIF signalling pathway
Cortisol has high affinity both for Gr and Mr and they have been recently shown to be differ-
entially involved in the regulation of stress axis activation and function in zebrafish [3]. There-
fore, we analysed the role of Mr on the HIF signaling pathway. To achieve this, we knocked-
outmr in gr+/-;vhl+/-;phd3:eGFP incross-derived embryos, using CRISPant technology [48,59].
Interestingly, phenotypic analysis performed on 5 dpf injected and uninjected larvae revealed
thatmr CRISPR injected vhlmutants were characterized by a significant downregulation of
phd3:eGFP-related brightness at the level of the head (equals to 49%, P<0.0001), in the liver
(equals to 56%, P<0.0001) and in the rest of the body (equals to 47%, P<0.0001), compared to
vhl-/-mutant uninjected larvae (Fig 6D compared to 6A). Moreover, when both gr andmr
were knocked-out, the downregulation was even stronger at the level of the head (equals to
62%, P<0.0001), in the liver (equals to 77%, P<0.0001) and in the rest of the body (equals to
63%, P<0.0001) compared to vhl-/-mutant uninjected larvae (Fig 6E compared to 6A). Of
note,mr injection in vhl-/- larvae was more efficient in downregulation of phd3:eGFP expres-
sion compared to uninjected gr-/-;vhl-/- larvae at the level of the head (equals to 31%,
P = 0.0087) (Fig 6D compared to 6B).
To test the reliability of CRISPant method, we chose to knock-out a gene (which was not
involved in the HIF pathway) into vhl+/- incross derived embryos, to test whether it was able to
affect HIF signalling. Laminin, beta 1b (lamb1b), which codes for an extracellular matrix glyco-
protein, was injected as CRISPR-injection control in vhl+/-incross derived embryos at 1 cell
stage. Genotypic analysis carried out on these larvae confirmed that these guides were effective.
Finally, quantification of phd3:eGFP-related brightness performed on 5 dpf injected and unin-
jected vhl-/- larvae, showed no significant differences between the two groups (S6A and S6C
Fig). Overall, these data corroborated the efficiency of the CRISPant method and, at the same
time, confirmed that both glucocorticoid and mineralocorticoid receptor play a pivotal role in
the HIF signalling in vivo.
Discussion
Both HIF and glucocorticoid mediated transcriptional responses play a pivotal role in tissue
homeostasis, glucose metabolism and in the regulation of cellular responses to various forms
of stress and inflammation [60–62]. Previous in vitro studies highlighted the potential for
crosstalk between HIF and glucocorticoid pathways, however there are still conflicting data on
how this interaction occurs in vivo and there is no information on Mr contribution to HIF sig-
nalling. In this regard, we have presented a novel in vivo study using zebrafish larvae, focusing
on the crosstalk between these two pathways. In contrast to in vitro cell culture studies, a
whole animal study allows us to consider the interactions that occur between various tissues
and provide novel insights. To this end, we generated arnt1 and gr null mutants to downregu-
late HIF and GR signalling respectively, as a basis for a genetic analysis of this crosstalk.
As a prelude to this, we had to establish the relative importance of arnt1 and arnt2 in the
overall HIF response. To achieve this, a discriminative test was devised to place them in a vhl
mutant background, where HIF signaling is strongly upregulated [25,42]. Phenotypic analysis
performed on 5 dpf arnt1-/-;vhl-/- larvae showed reduced phd3:eGFP related brightness, normal
yolk usage, properly developed and air-filled swim bladder as well as by the absence of pericar-
dial oedema and excessive caudal vasculature. However, beyond 5 days, these double mutants
exhibited only partial recovery from the vhl phenotype. Indeed, they developed well till 15 dpf,
but subsequently failed to grow and thrive when compared to their siblings. In addition, arnt1
homozygous mutants were found to be viable and fertile, in contrast to both homozygous vhl
and arnt2mutants, which are embryonic lethal by 8–10 dpf [14,47].
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Even though Arnt1 is not fundamental for survival, we found that it is required in the liver
and in organs outside the central nervous system for HIF−ċ function. Conversely, using CRIS-
Pant technology [48,59], we established that Arnt2 is mainly required in the developing central
nervous system (CNS), as also reported by Hill et al. in 2009 [14]. However, the similarities
observed in terms of phd3:eGFP-induced brightness in both arnt1-/-;vhl-/- and arnt2 CRISPR
injected vhlmutants, suggest there is no strong functional separation. Therefore, both Arnt2
Fig 5. BME treatment is able to upregulate HIF signalling in vhl-/-. A-B’. Representative pictures of WISH performed on DMSO (A-B) and BME
[30 μM] (A’-B’) treated vhl+/- incross derived larvae, at 5 dpf, using ldha as probe. DMSO treated vhl siblings showed basal ldha expression (34/35 larvae),
which showed to be upregulated after BME treatment (33/35 larvae). On the other hand, DMSO treated vhl-/- showed upregulated ldha expression (32/35
larvae), which was further upregulated after BME treatment (34/35 larvae). (black arrowhead: head and liver) Chi-square test (����P< 0.0001). Scale bar
200 μm. C-D’. Representative pictures of WISH performed on DMSO (C-D) and BME [30 μM] (C’-D’) treated vhl+/- incross derived larvae, at 5 dpf, using
phd3 (egln3) as probe. As expected, vhl siblings DMSO treated (n = 30/30 larvae) showed basal phd3 expression, which was mildly increased after BME
treatment (n = 27/30 larvae). Vhl-/- DMSO treated (n = 28/30 larvae) showed upregulated phd3 expression, which was further increased after BME
treatment (n = 26/30 larvae). (black arrowhead: head and liver) Chi-square test (����P< 0.0001). Scale bar 200 μm.
https://doi.org/10.1371/journal.pgen.1008757.g005
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and Arnt1 have partially overlapping functions in vivo and both contribute to the HIF
response.
The effect of HIF signalling on the glucocorticoid pathway
We next investigated the effect of HIF signalling and glucocorticoid responsiveness, by per-
forming RTqPCR analysis on 5 dpf larvae. Collectively, we show that strong activation of HIF
signalling (in vhl-/-) is able to blunt glucocorticoid receptor transcriptional regulation as judged
by fkbp5 expression, whereas arnt1 loss of function derepressed it. As our experiments are
done at normal atmospheric oxygen levels, we conclude from the latter result that normoxic
HIF activity nevertheless suffices to attenuate GR transcriptional regulation.
We checked whether HIF signalling affects steroidogenesis. To this end, we quantified the
expression of steroidogenesis-related genes (pomca and cyp17a2) both in vhl-/- and in arnt1-/-
larvae, via whole-mount in situ hybridization. Surprisingly, both lines showed downregulation
of pomca expression. However, arnt1-/- larvae showed upregulated cyp17a2 expression,
whereas vhl-/- larvae, were characterized by downregulated cyp17a2.
Considering our results with GR-target fkbp5 in these mutants, we assume that in an arnt1
knock-out scenario, pomca downregulation occurs as a consequence of the GC/GR-mediated
negative feedback loop aimed to control cortisol biosynthesis. This is also consistent with a sig-
nificant upregulated basal cortisol levels quantified in these mutants. Vice versa, when HIF sig-
nalling is upregulated (in vhlmutants) we speculate that pomca and cyp17a2 downregulation
may occur via HIF-mediated activity, leading to the observed low cortisol levels coupled to
suppressed GR activity.
Indeed, glucocorticoids regulate a plethora of physiological processes, act on nearly every
tissue and organ in the body to maintain homeostasis and are characterized by a potent anti-
Fig 6. Both Gr andMr are directly required in the HIF signalling pathway.A-F. Representative pictures of 5 dpf CRISPANTmutants
created by redundantly targeting nr3c2 (mr) gene via co-injection of 4x gRNAs in gr+/-;vhl+/-(phd3:eGFP) x gr-/-; vhl+/-(phd3:eGFP)
derived embryos (n = 344). Uninjected embryos were used as control (n = 170). Fluorescence, exposure = 991,4 ms. Scale bar 500 μm. G.
Statistical analysis performed on mean grey value quantification (at the level of the head, liver and tail), after phenotypic analysis, on 5
dpfmr 4x gRNAs injected and uninjected larvae. vhl-/- uninjected n = 17 larvae: head 48.28 ± 2.99 (mean ± s.e.m); liver 46.47 ± 3.55
(mean ± s.e.m); tail 16.15 ± 1.06 (mean ± s.e.m). gr-/-;vhl-/- uninjected n = 8 larvae: head 35.48 ± 2.03 (mean ± s.e.m); liver 23.56 ± 1.72
(mean ± s.e.m); tail 10.98 ± 0.75 (mean ± s.e.m). vhl-/- injected n = 15 larvae: head 24.62 ± 0.97 (mean ± s.e.m); liver 20.67 ± 1.1
(mean ± s.e.m); tail 8.57 ± 0.39 (mean ± s.e.m). gr-/-;vhl-/- injected n = 16 larvae: head 18.33 ± 0.46 (mean ± s.e.m); liver 10.71 ± 0.56
(mean ± s.e.m); tail 6.07 ± 0.26 (mean ± s.e.m); ordinary One-way ANOVA followed by Sidak’s multiple comparison test.
https://doi.org/10.1371/journal.pgen.1008757.g006
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inflammatory and immunosuppressive actions. For these reasons, their secretion must be
finely controlled by the HPA/I axis [63].
As previous work in our laboratory showed that glucocorticoids also act as HIF activators
[25,43], we infer that HIF can in turn control GC levels by acting on pomca. This would enable
HIF signalling not only to control its own levels, but also to assure homeostasis. Finally, since
HIF signalling is a master regulator of cellular pro-inflammatory responses to hypoxia [64–
66], which would counteract the anti-inflammatory glucocorticoid activity, we speculate that
the simultaneous expression of both upregulated HIF and GC pathway would be detrimental
to homeostasis.
Our data would also be in accordance with a previous study showing that hypoxia exposure
resulted in downregulation of steroidogenic genes (StAR, cyp11c1, hmgcr, hsd17b2, cyp19a,
cyp19b) in 72 hpf larvae, whereas zHIF-ċ loss of function triggered the upregulation specifi-
cally of StAR, cyp11b2 and cyp17a1 [67].
Cumulatively, if this is true, we predicted to observe reduced levels of endogenous glucocor-
ticoids in vhl-/- and normal or even increased levels in arnt1-/-. Importantly, the fact that corti-
sol levels were lowered in vhlmutants and were upregulated in arnt1mutants is consistent
with our hypothesis.
As a consequence of the above considerations, the HIF-mediated pomca negative regulation
seems to be a logic homeostatic interaction: Increased HIF reduces GR activity, which in turn
should lead to less HIF signalling.
The effect of glucocorticoids on the HIF signaling pathway
To further investigate the role of glucocorticoids on the HIF signalling, we initially analyzed the
effect of gr loss of function on vhl phenotype. Surprisingly, we observed that grmutation was
able to cause an efficient, but not complete rescue of the vhl phenotype. Notably, gr-/-;vhl-/- sur-
vived much longer than vhl-/- (> = 21 dpf compared to max. 10 dpf), but then similar to
arnt1-/-;vhl-/-, they failed to grow and thrive when compared to siblings. Our previous work [43]
established that activation of GR signalling negatively regulates VHL protein in human liver
cells. Our current genetic analysis shows that in zebrafish larvae, there must be an additional
point of interaction between these two pathways, as we observed further activation of our HIF
reporter after GR treatment even in the absence of VHL. Cumulatively, we showed for the first
time in an in vivo animal model that Gr is fundamental to allow high HIF signalling levels.
We next analysed the effect of betamethasone treatment in arnt1-/-. Although BME acti-
vated the GR target fkbp5, as expected, it failed to activate HIF signaling [43]. This was unex-
pected and would be best explained by assuming that a Gr-BME complex would preferentially
interact with a HIFċ/ARNT1 complex but not a HIFċ/ARNT2 complex. Whether this holds
up in mammalian cells would be interesting to address.
Evaluation of mineralocorticoid receptor contribution to HIF signalling
Recent work published by Faught and Vijayan, 2018 showed that both Gr and Mr are involved
in the regulation of zebrafish stress axis activation and function [3]. Nothing is known about
mineralocorticoid receptor contribution to HIF signalling. Therefore, we tested the effect of
mr knock-out in gr+/-;vhl+/-;phd3:EGFP incrossed derived embryos. Interestingly, inmr
injected- vhl-/- we observed a significant reduction of phd3:eGFP-related brightness, compared
to uninjected vhl-/- larvae. Moreover, a further reduction of phd3:eGFP expression was found
at the level of the head inmr injected- vhl-/- compared to gr-/-;vhl-/- larvae. Finally, the addi-
tional removal ofmr in a gr-/-;vhl-/- background could reduce the hypoxia reporter expression
even further.
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Therefore, we were able to show that both the glucocorticoid receptor and mineralocorti-
coid receptor play a pivotal role in promoting HIF signaling in zebrafish. In contrast to mam-
mals, teleosts lack aldosterone and cortisol is the primary glucocorticoid hormone that can
interact both with Gr and Mr to assure a correct HPI axis activity [68,69]. Of note, Mr was
shown to not have a role in rapid non-genomic behaviors that required HPI axis signaling in
zebrafish [70]. However, our hypothesis is consistent with Faught and Vijayan, 2018 elegant
work, showing that both Gr and Mr signalling are involved in the GC negative feedback regu-
lation. Importantly, this outcome may have a wider significance in health and disease. This is
because so far, the HIF signalling, which play a key role in tumour growth, is proven difficult
to downregulate. In this regard, our study suggests that modulation of Gr and Mr might be a
potential avenue. In conclusion, although Mr contribution to HIF response in other organisms
remains unclear, our work suggests that research into its function is warranted.
Conclusion
Our present study stresses the importance of the glucocorticoid pathway in driving HIF signal-
ling. In addition, we uncovered a negative regulatory role played by HIF in regulating both GR
responsiveness and steroidogenesis as demonstrated via RTqPCR and steroid hormone quanti-
fication. We also identify a mineralocorticoid receptor contribution to HIF-GC crosstalk.
Finally, we presented novel gr+/-;vhl+/-, arnt1+/-;vhl+/- and arnt1+/-;gr+/-;vhl+/- zebrafish mutant
lines which helped to better understand how the interplay between HIF and glucocorticoids
occur in vivo. For these reasons, we believe that this work could pave the way for further in vivo
analysis to precisely identify the extensive crosstalk behind these two major signalling pathways.
Materials and methods
Ethics statement
Zebrafish (Danio rerio) lines were raised and maintained under standard conditions (14 hours
of light and 10 hours of dark cycle, at 28˚C) in the Aquaria facility of the University of Shef-
field. Zebrafish embryos used for experiments were reared in E3 medium (5 mMNaCl, 0.17
mM KCl, 0.33 mMMgCl2, 0.33 mM CaCl2, pH 7.2) with or without methylene blue (Sigma-
Aldrich) and staged according to standard methods [71] for up to 5,2 days post fertilisation
(dpf) in accordance with UK Home Office legislation. Our studies conform with the UK
Home Office guidelines (ASPA), Licence No. PC9C3D4CB and PB2866ED0. Ethics approval
was obtained from the University of Sheffield Ethics committee AWERB.
Zebrafish strains
The following zebrafish lines were used: wild-type (wt) strain AB (ZDB-GENO-960809-7),
vhlhu2117/+;phd3:eGFPi144/i144 (ZDB-GENO-090611-18), hif1Čsh544/+; hif1Čsh544/+;vhlhu2117/+,
grsh543/+, grsh543/+;vhlhu2117/+, grsh543/+;hif1Čsh544/+; and grsh543/+;hif1Čsh544/+;vhlhu2117/+ lines
were generally maintained in a phd3:EGFPi144/+ background. The following 4x gRNAs
CRISPR-injected G0 null mutant lines were created according to Wu et al, 2018 [48] protocol
and raised up to to 5,2 dpf:mr;grsh543/+;vhlhu2117/+;phd3:eGFPi144/+, hif1Č2;1hif1Čsh544/+;
vhlhu2117/+;phd3:eGFPi144/+ and lamb1b;vhlhu2117/+;phd3:eGFPi144/+ (used as CRISPR injection
control).
Generation of gr (nr3c1) and hif1Č (arnt1) null zebrafish lines
Both nr3c1mutant line (grsh543/+) and arnt1mutant line (hif1Čsh544/+) were generated using the
CRISPR/Cas9-based mutagenesis method. A gene-specific guide RNA (sgRNA) sequence was
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identified using the CHOPCHOP website [72,73]. To design both gr and arnt1 sgRNA, an 18
nucleotides sequence upstream to a selected PAM site (grsh543: CCAGCTGACGATGTGG
CAG; hif1Čsh544: TCGGTGCTGGTGTTTCCAG) was inserted into a scaffold sequence [74],
containing a promoter for the T7 Polymerase. The sgRNA was amplified via PCR, purified
from agarose gel and in vitro transcribed using MEGAshortscript T7 kit (Ambion). 1 nl of
CRISPR mixture containing 2,4 μg/μl of gRNA and 0.5 μl Cas9 protein (NEB) was injected in
one-cell stage embryos and raised for 24 hours. Wild-type (wt), strain AB embryos were used
to generate the grmutant line, whereas vhlhu2117/+;phd3:eGFPi144/+ incross-derived embryos
were used to create the hif1Čmutant line. Efficiency was verified via whole-embryo PCR-based
genotyping, by a diagnostic restriction digest. Injected embryos were raised to adulthood.
Embryos collected from transmitting G0 founders crossed with WT(AB) fish were raised and
genotyped to confirm germline transmission of the mutation (F1 generation). Heterozygous
mutants, carrying the same mutation, were selected and crossed to obtain homozygous mutant
embryos (F2 generation).
Generation of CRISPR/Cas9-mediated mutants (CRISPANTs)
To generate G0 knockout embryos we used the method developed by Burger et al 2016 [59]
and improved byWu et al., 2018 [48]. In short, a pool of four guide-RNAs (25μM each, Sigma
Aldrich) were co-injected with 0.5 μl Cas9 protein (NEB, M0386, 20μM), diluted 1:10) and 1 μl
tracrRNA (100μM) in one-cell stage embryos. This method was used to create G0 CRISPANTs
for the following genes of interest:mineralocorticoid receptor (mr, nr3c2), aryl hydrocarbon
receptor nuclear translocator 2 (arnt2, hif1Č2) and laminin, beta 1b (lamb1b). The latter was
used as CRISPR-injection control. The gRNA target sequences used in this study are as fol-
lows: arnt2: gRNA1-ACGGCGCCTACAAACCCTCC (exon 5), gRNA2-GGCCGATGGC
TTCTTGTTCG (exon6), gRNA3-TTCACGCCACAATTCGGATG (exon11), gRNA4-GTC
GCAGGTGCGTAAAAACA (exon 14); nr3c2: gRNA1-GCATTGTGGGGTCACCTCCA
(exon 2), gRNA2-AAGGGGATTAAACAGGAAAC (exon 2), gRNA3-CAACCAGCTCGC
CGGAAAAC (exon 5), gRNA4-ATATCTGACGCCGTCCGTCT (exon 5); lamb1b gRNA1-
TTGTTAATAGCATAGTACATTGG (sequence upstream 5’UTR), gRNA2-GGAGAAC
AAGCAAAACGATGAGG (ATG), gRNA3- GCGTGGTGCAGGGTTTGTAG (5’UTR),
gRNA4- TCACAATGACATGTGTGCG (exon 2). The success of the injection was deter-
mined via phenotypic analysis, followed by quantification of phd3:eGFP related brightness and
whole-embryo PCR-based genotyping performed on a fraction of injected embryos at 5 dpf.
Whole-mount in situ hybridisation
Whole-mount in situ hybridization (WISH) was performed according to standard protocols
[75]. The following antisense RNA probes were used: proopiomelanocortin a (pomca) created
as previously described [76]; Cytochrome P450 family 17 polypeptide 2 (cyp17a2), created as
previously described [55], both prolyl hydroxylase 3 (phd3; BC066699), and lactate dehydroge-
nase A (ldha1; BC067188) probes, generated as previously described [25,47].
Embryos harvesting, drug treatment and fixation for WISH
Embryos intended for whole-mount in situ hybridisation were treated with 16,8 μl of 1-phenyl
2-thiourea (PTU, stock concentration 75mg/ml) diluted into 35 ml E3 medium to inhibit
melanogenesis, according to Karlsson et al., 2001 [77]. GR agonist treatment was performed
on batches of 15 embryos each, at 4 dpf, treated in 6-well plates, with 30 μMBetamethasone
17,21-dipropanoate (BME) and with 1% DMSO (Sigma-Aldrich), as control, for 24 hours [4].
Inside the 6-well plates, embryos were incubated in 3 ml total volume of E3 medium, without
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methylene blue. Afterwards, up to 30 embryos at 5 dpf were collected in 1,5 ml Eppendorf
tubes and anaesthetized using Tricaine Solution (MS-222, Sigma Aldrich) prior to fixation in 1
ml 4% PFA solution overnight, at 4˚C. Embryos were then washed twice for 10 minutes in
PBST and post-fixed in 1 ml 100%MeOH. Finally, samples were stored at -20˚C.
grsh543mutants sorting by visual background adaptation (VBA)
Visual background adaptation (VBA) is a glucocorticoid receptor-dependent neuroendocrine
response which causes zebrafish melanocytes to shrink when exposed to bright illumination
[78,79]. To identify grsh543 mutants from siblings and to confirm the absence of a functional
VBA response, 5dpf larvae were exposed to 30 minutes darkness and then transferred onto a
white background under bright, whole-field illumination, using a 30W fluorescent lamp
mounted 50 cm above the dish [80,81].
Cortisol extraction and quantification
Three biological replicates of 150 larvae at 5 dpf each of hif1Čsh544mutants, hif1Čsh544 siblings,
vhlhu2117mutants and vhlhu2117 siblings, respectively, were used for steroid hormone extraction
and quantification. vhl-/- larvae were sorted among siblings at 4 dpf according to both their
phenotype and phd3:eGFP-related brightness. Because of the lack of visible phenotype, arnt1-/-
larvae where derived from arnt1-/- fish incrossed, whereas siblings were from arnt1+/- fish
crossed with arnt1+/+ ones. Cortisol quantification was carried out according to the protocol
published by Eachus et al., 2017 [55], based on the use of an Acquity UPLC System (Waters,
Milford, CT) coupled to a Xevo TQ-S tandem mass spectrometer (Waters).
RNA isolation, cDNA synthesis and qPCR analysis
Transcript abundance of target genes was measured by quantitative real-time PCR (RTqPCR).
Three biological replicates of 10 larvae at 4 dpf each, were treated for 24 hours with 30 μM
Betamethasone 17,21-dipropanoate and with 1% DMSO, used as control, prior to RNA isola-
tion. Total RNA was extracted from pools of 10 larvae at 5dpf with TRIzol reagent (Invitrogen
by Thermo Fisher Scientific, 15596026). RNA extracted was quantified using a Nanodrop ND-
1000 spectrophotometer. cDNA was then synthesized from 1μg RNA template through reverse
transcription using Protoscript II First Strand cDNA Synthesis Kit (New England Biolabs), as
recommended by manufacturer’s instructions. All RTqPCR reactions were performed in trip-
licate using TaqMan probes in combination with CFX96 Touch Real-Time PCR Detection
System (BioRad), paired with CFXMaestro Analysis Software.
Each reaction mixture (20 μl) reaction mixture containing 1 μl cDNA template (100ng/ml),
1 μl FAM probe and 10 μl TaqMan Universal Master Mix (Applied biosystems by Thermo
Fisher Scientific, Epsom, UK) was amplified as follows: denaturation at 95˚C for 10 minutes
and 39 cycles at 95˚C for15 seconds, 60˚C for 30 seconds. Four hypoxia-inducible factor path-
way-dependent genes (egln3: Dr03095294_m1, pfkfb3: Dr03133482_m1, vegfab: Dr03072613_
m1 and slc2a1a: Dr03103605_m1) and four glucocorticoid pathway-dependent target genes
(fkbp5:Dr03114487_m1, il6st: Dr03431389_m1, pck1: Dr03152525_m1 and lipca: Dr03113728_
m1) were quantified in the present study (Applied biosystems by Thermo Fisher Scientific,
Epsom, UK).
Expression levels for each gene were normalized to eef1a1 (Dr03432748_m1) and/or rps29
(Dr03152131_m1) and fold change values were generated relative to wild-type DMSO treated
control levels, according to ïïCTmethod [82]. All data were expressed as fold change
mean ± s.e.m and P ฀ 0.05 was considered statistically significant.
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Quantifying phd3:eGFP-related brightness
Images were acquired using Leica Application Suite version 4.9, which allowed the capture
both of bright-field and GFP fluorescent images. To quantify the phd3:eGFP-related brightness
of live embryos derived from each incrossed mutant line used in this project, Fiji (Image J)
software v.2.0.0 was used. Images were converted into a grey scale 8-bit format and subse-
quently analysed by the software, by summing the grey values of all the pixels in the selected
area, divided by the number of pixels. By default, since values equal 0 are assigned to black and
values equal to 255 to white, the quantified mean grey values are proportional to the intensity
of the eGFP-related brightness expressed in the embryos. In particular, head, liver and tail
(from the anus to the caudal peduncle) related brightness were selected and measured in all
the mutant lines used in this study (S1D Fig). Genotyping post phenotypic analysis on phd3:
eGFP sorted larvae confirmed the genotype-phenotype correlation.
Statistical analysis
GraphPad Prism version 8.0 for MacOS (GraphPad Software, La Jolla, California, USA, www.
graphpad.com) was used to perform statistical analysis on all the samples analysed. Unpaired t
tests were used to test for significant differences between two sample groups (i.e cortisol quan-
tification). One-way ANOVA was used for assessing mean grey values data quantification,
whereas two-way ANOVA was used to evaluate qPCR data. As post-hoc correction tests,
Sidak’s method for multiple comparisons was used on normally distributed populations fol-
lowing one-way ANOVA, while Dunnett’s correction was used for comparing every mean to a
control mean, on normally distributed populations following two-way ANOVA.
Supporting information
S1 Fig. arnt1-/-; vhl-/- larvae showed a reduced phd3:eGFP brightness and a partially res-
cued vhl phenotype. A. Statistical analysis performed on mean gray value quantification (at
the level of the head, liver and tail), after phenotypic analysis on 5dpf DMSO and BME [30μM]
treated arnt1+/-;vhl+/-(phd3:eGFP) x arnt1-/-; vhl+/-(phd3:eGFP) derived larvae (n = 540). vhl-/-
DMSO treated n = 17 larvae: head 166.67 ± 9.63 (mean ± s.e.m); liver 138.61 ± 12.05
(mean ± s.e.m); tail 50.31 ± 4.51 (mean ± s.e.m). arnt1-/-;vhl-/-DMSO treated n = 13 larvae:
head 121.05 ± 6.99 (mean ± s.e.m); liver 49.61 ± 3.88 (mean ± s.e.m); tail 21.75 ± 1.12
(mean ± s.e.m). vhl-/- BME treated n = 18 larvae: head 199.88 ± 7.71 (mean ± s.e.m); liver
222.57 ± 8.72 (mean ± s.e.m); tail 57.57 ± 4.11 (mean ± s.e.m). arnt1-/-;vhl-/- BME treated
n = 12 larvae: head 153.71 ± 8.66 (mean ± s.e.m); liver 62.58 ± 5.16 (mean ± s.e.m); tail
25.82 ± 1.54 (mean ± s.e.m). Ordinary One-way ANOVA followed by Sidak’s multiple com-
parison test (�P< 0.05; ��P< 0.01; ���P<0.001; ����P< 0.0001). B. Kaplan-Meier survival
curves of the zebrafish arnt1+/-; vhl+/-(phd3:eGFP) genotype analysed in this study. Time is
shown in days. Siblings n = 30; arnt1-/-; vhl-/-(phd3:eGFP) n = 8. The Log-rank (Mantel-Cox)
test was used for statistical analysis. arnt1-/-; vhl-/-(phd3:eGFP) vs. siblings: ��P< 0.0027. C.
RTqPCR analysis performed on arnt1 siblings (n = 10; 3 repeats) and arnt1-/- (n = 10; 3
repeats) larvae at 5 dpf, using egln3 as probe. Statistical analysis was performed on ïïCt values,
whereas data are shown as fold change values. Ordinary Two-way ANOVA followed by Dun-
nett’s multiple comparison test (���P<0.001;����P< 0.0001). D. Representative picture of
head, liver and tail areas selected in each larva to quantify the phd3:eGFP-related brightness
via mean grey value quantification (Fiji, ImageJ software).
(TIF)
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S2 Fig. GC target genes expression in the presence of high, moderately upregulated and
suppressed HIF signalling pathway. Schematic view of RTqPCR analysis on il6st, pck1 and
lipca (GC target genes) expression performed on the following mutant lines: vhl+/-(phd3:
eGFP), arnt1+/-;vhl+/-(phd3:eGFP) and arnt1+/-(phd3:eGFP). Statistical analysis performed on
ïïCt values; data are shown as fold change values for RTqPCR analysed samples; ordinary
Two-way ANOVA followed by Dunnett’s multiple comparison test (�P< 0.05; ��P< 0.01;
���P<0.001; ����P< 0.0001).
(TIF)
S3 Fig. gr-/-; vhl-/- larvae showed a reduced phd3:eGFP brightness and a partially rescued
Vhl phenotype. A-D’. Representative pictures of WISH performed on DMSO and BME
[30 μM] treated arnt1 mutant line, at 5 dpf, using cyp17a2 as probe. A-A’) arnt1 wt DMSO
treated larvae (n = 26/28) showed normal cyp17a2 expression, whereas 2/28 larvae showed a
weaker one; B-B’) arnt1 wt BME treated larvae (n = 28/30) showed downregulated cyp17a2
expression, whereas 2/30 larvae showed a normal one. C-C’) In contrast, arnt1-/-DMSO
treated larvae (n = 24/28) showed upregulated cyp17a2 expression, whereas 4/28 larvae showed
a weaker one. D-D’) arnt1-/- BME treated larvae (n = 25/29) showed downregulated cyp17a2
expression, whereas 4/29, showed a normal one. Chi-square test (����P< 0.0001). Scale bar
200 μm. E-H’. Representative pictures of WISH performed on DMSO and BME [30 μM]
treated vhlmutant line, at 5 dpf, using cyp17a2 as probe. E-E’) DMSO treated vhl siblings
(n = 18/21) showed normal cyp17a2 expression, whereas 3/21 larvae showed a weaker one;
F-F’) BME treated vhl siblings (n = 28/30) showed downregulated cyp17a2 expression, whereas
2/30 larvae showed a normal one. G-G’) On the other hand, vhl-/-DMSO treated larvae
(n = 27/28) showed weak cyp17a2 expression, whereas 1/28 larvae showed a normal one.
H-H’) vhl-/- BME treated larvae (n = 30/30) showed downregulated cyp17a2 expression. Chi-
square test (����P< 0.0001). Scale bar 200 μm. I-I’. Representative picture of the colour thresh-
old area calculation method (ImageJ software’s tool) used to quantify the area occupied by the
cyp17a2WISH staining both in arnt1 siblings (n = 9) and arnt1-/- (n = 9). I’. unpaired t-test
(����P<0.0001).
(TIF)
S4 Fig. gr-/-; vhl-/- larvae showed a reduced phd3:eGFP brightness and a partially rescued
vhl phenotype. A. Statistical analysis performed on mean gray value quantification (at the
level of the head, liver and tail), after phenotypic analysis on 5dpf DMSO and BME [30μM]
treated gr+/-;vhl+/-(phd3:eGFP) x gr-/-; vhl+/-(phd3:eGFP) derived larvae (n = 600). vhl-/- DMSO
treated n = 9 larvae: head 186 ± 15.12 (mean ± s.e.m); liver 177.01 ± 20.85 (mean ± s.e.m); tail
62.34 ± 7.27 (mean ± s.e.m). gr-/-;vhl-/- DMSO treated n = 7 larvae: head 106.96 ± 3.21
(mean ± s.e.m); liver 60.75 ± 2.56 (mean ± s.e.m); tail 30.67 ± 1.27 (mean ± s.e.m). vhl-/- BME
treated n = 14 larvae: head 224.32 ± 6.83 (mean ± s.e.m); liver 244.07 ± 5.31 (mean ± s.e.m);
tail 80.51 ± 5.49 (mean ± s.e.m). gr-/-;vhl-/- BME treated n = 9 larvae: head 125.85 ± 3.6
(mean ± s.e.m); liver 63.56 ± 2.91 (mean ± s.e.m); tail 33.67 ± 1.02 (mean ± s.e.m). Ordinary
One-way ANOVA followed by Sidak’s multiple comparison test (�P< 0.05; ��P< 0.01; ���P
<0.001; ����P< 0.0001). B. Kaplan-Meier survival curves of the zebrafish gr+/-; vhl+/-(phd3:
eGFP) genotype analysed in this study. Time is shown in days. Wild-types n = 20; gr+/-; vhl+/-
n = 20; gr-/-; vhl-/-(phd3:eGFP) n = 5. The Log-rank (Mantel-Cox) test was used for statistical
analysis. gr-/-; vhl-/-(phd3:eGFP) vs. gr+/-; vhl+/-, ����P< 0.0001; gr-/-; vhl-/-(phd3:eGFP) vs. wt,
����P< 0.0001.
(TIF)
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S5 Fig. gr-/-;arnt1-/-;vhl-/- showed an even more reduced phd3:eGFP brightness. Statistical
analysis performed on mean gray values quantification (at the level of the head, liver and tail),
after phenotypic analysis on 5dpf gr+/-;arnt1+/-vhl+/-(phd3:eGFP) incross-derived GFP+ larvae
(n = 488). vhl-/- n = 5 larvae: head 125.82 ± 13.05 (mean ± s.e.m); liver 98.52 ± 3.8 (mean ± s.e.
m); tail 37.43 ± 2.45 (mean ± s.e.m). gr-/-;arnt1-/-;vhl-/- n = 5 larvae: head 40.24 ± 2.46
(mean ± s.e.m); liver 26.07 ± 1.31 (mean ± s.e.m); tail 11.22 ± 0.47 (mean ± s.e.m); unpaired t-
test (���P = 0.0002; ����P< 0.0001).
(TIF)
S6 Fig. CRISPR/Cas9 injection per se does not affect HIF signalling. A-D. Representative
pictures of 5 dpf CRISPANT mutants created by redundantly targeting lamb1b gene via co-
injection of 4x gRNAs in vhl+/-(phd3:eGFP) incross-derived embryos (n = 400). Uninjected
embryos were used as control (n = 470). Fluorescence, exposure = 991,4 ms. Scale bar 500 μm.
E. Statistical analysis performed on mean grey values quantification (at the level of the head,
liver and tail), after phenotypic analysis on 5 dpf lamb1b 4x gRNAs injected and uninjected
vhl+/-(phd3:eGFP) incross-derived larvae. vhl-/- uninjected n = 24 larvae: head 54.83 ± 3.68
(mean ± s.e.m); liver 77.86 ± 6.46 (mean ± s.e.m); tail 19.56 ± 1.43 (mean ± s.e.m). vhl-/-
injected n = 25 larvae: head 59.74 ± 4.05 (mean ± s.e.m); liver 83.23 ± 5.92 (mean ± s.e.m); tail
19.9 ± 1.38 (mean ± s.e.m); unpaired t-test (all panels: �P< 0.05; ��P< 0.01; ���P<0.001;
����P< 0.0001).
(TIF)
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